Lv7
3220 积分 2023-05-24 加入
Breaking the therapeutic ceiling in drug development in ulcerative colitis
7天前
已完结
Ulcerative colitis
23天前
已完结
Ulcerative colitis, pathophysiological mechanisms and drug repurposing: a new therapeutic dawn-narrative review
1个月前
已完结
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis
1个月前
已完结
Biological, genetic and epigenetic markers in ulcerative colitis
1个月前
已完结
A Simplified Definition of Histologic Improvement in Ulcerative Colitis and its Association With Disease Outcomes up to 30 Weeks from Initiation of Therapy: Post Hoc Analysis of Three Clinical Trials
1个月前
已完结
Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY)
1个月前
已完结
Histologic Evaluation Using the Robarts Histopathology Index in Patients With Ulcerative Colitis in Deep Remission and the Association of Histologic Remission With Risk of Relapse
1个月前
已完结
Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin Levels
1个月前
已完结
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
1个月前
已完结
皖公网安备34019202002308
